{"id":44,"date":"2025-02-12T12:47:59","date_gmt":"2025-02-12T12:47:59","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/?page_id=44"},"modified":"2025-05-20T06:07:27","modified_gmt":"2025-05-20T06:07:27","slug":"estudio-epidemiologico-en-la-demencia-frontotemporal-efront","status":"publish","type":"page","link":"https:\/\/www.centogene.com\/es\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/","title":{"rendered":"EFRONT"},"content":{"rendered":"<section class=\"bloque-banner-titulo-page  estilo-grey\" id=\"\">\r\n    \r\n    <div class=\"image-wrapper\">\r\n\r\n      <!-- include mp4 video on a loop -->\r\n              <img decoding=\"async\" class=\"\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/csm_centogene-pharma-case-studies_efront-header_aaebfd0a29.webp\" alt=\"csm_centogene-pharma-casos-de-estudio_efront-header_aaebfd0a29\" \/>\r\n          <\/div>\r\n    <div class=\"container content-wrapper\">\r\n      <div class=\"row justify-content-start align-items-center\">\r\n\r\n\r\n        <div class=\"col-12 col-lg-6 animation fadeTop align-self-center\">\r\n                  <h1>EFRONT<\/h1>\r\n          <h2 class=\"bl-texto\">Estudio epidemiol\u00f3gico en la demencia frontotemporal<\/h2>                            <\/div>\r\n\r\n      <\/div>\r\n    <\/div>\r\n\r\n<\/section>\r\n<div class=\"breadcrumbs\">\r\n    <div class=\"container\">\r\n      <div class=\"row\">\r\n        <div class=\"col-12\">\r\n          <ul id=\"breadcrumbs\" class=\"breadcrumbs\"><li><a href=\"https:\/\/www.centogene.com\/es\/\">Inicio<\/a><\/li><\/ul>        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Resumen<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Fondo<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">EFRONT es un estudio multic\u00e9ntrico, de visita \u00fanica y no intervencionista que investiga la prevalencia de etiolog\u00edas gen\u00e9ticas en la demencia frontotemporal (DFT) mediante la genotipificaci\u00f3n de pacientes diagnosticados o sospechosos de DFT.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La DFT es una enfermedad neurodegenerativa gen\u00e9tica y patol\u00f3gicamente heterog\u00e9nea causada por la p\u00e9rdida o da\u00f1o de c\u00e9lulas nerviosas en los l\u00f3bulos frontal y temporal del cerebro. Como resultado, se presentan anomal\u00edas en el comportamiento, la personalidad y problemas de comprensi\u00f3n del lenguaje, como falta de inter\u00e9s, juicio, p\u00e9rdida de empat\u00eda y apat\u00eda.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">    <section class=\"bloque-personalizado bloque-cajas-imgs estilo-cajasblancas\" >\n        <div class=\"\"> \n                        <div class=\"row justify-content-between\">\n\n                                        \n                <div class=\"swiper-slide col-12 delay-1 caja\">\n                    <div class=\"caja-inner\" >\n                        <a href=\"https:\/\/www.centoportal.com\/\" target=\"_blank\" class=\"\">                        <div class=\"bl-imagen animationNo scalexTop delay-1\"><img decoding=\"async\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/csm_centogene-pharma-clinical-trials_study-access-teaser-card_7fbd33e2a0-650x400.webp\" class=\"\" alt=\"\" \/> <\/div>                                               \n                        <\/a>                        \n                        <div class=\"caja-text\">\n                            <p class=\"prefijo\">Ensayos cl\u00ednicos<\/p>                            <h3 class=\"bl-titulo\">Acceso al estudio en CentoPortal\u00ae para los m\u00e9dicos participantes<\/h3>\n                                  \n                                                          <a target=\"_blank\" href=\"https:\/\/www.centoportal.com\/\" class=\"btn btn-primary\">CentoPortal\u00ae<\/a>\n                                                                          \n                        <\/div>                        \n                        \n                    <\/div>      \n                <\/div>       \n                \n                                     \n             \n            \n        <\/div>\n    <\/div>  \n<\/section>\n\n\n\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    fondocolor\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<h2 class=\"wp-block-heading\">Fundamento y procedimiento del estudio<\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\">Fundamento del estudio<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">La DFT es una enfermedad neurodegenerativa poco frecuente y la forma m\u00e1s com\u00fan de demencia en personas menores de 60 a\u00f1os. Afecta a aproximadamente 110.000 pacientes en la Uni\u00f3n Europea y a una cifra estimada de entre 50.000 y 60.000 en Estados Unidos. A diferencia de otras enfermedades neurol\u00f3gicas, la DFT comparte fenotipos cl\u00ednicos similares, lo que dificulta su diagn\u00f3stico.<\/p>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">Hasta el 301% de todos los casos de FTD4T en todo el mundo son causados por mutaciones gen\u00e9ticas, incluida la mutaci\u00f3n del gen de la progranulina (FTD- <em>GRN<\/em> ).<\/p>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">El estudio FTD- <em>GRN<\/em> abarca desde el 5% hasta el 10% en pacientes con FTD, y muchos otros presentan una causa gen\u00e9tica de esta enfermedad. Para determinar mejor las diversas causas gen\u00e9ticas y las diferencias fenot\u00edpicas, este estudio busca comprender mejor la patobiolog\u00eda y la gen\u00e9tica de la FTD. El objetivo de este estudio cl\u00ednico es reclutar a 4500 participantes en centros de estudio en Alemania, Espa\u00f1a, Italia, Portugal, B\u00e9lgica, Turqu\u00eda y Grecia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Descubre c\u00f3mo puedes participar:&nbsp;<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05075187?term=EFRONT&amp;draw=2&amp;rank=1\" target=\"_blank\" rel=\"noreferrer noopener\">ClinicalTrials.gov<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Actualmente no existen opciones de tratamiento aprobadas por la FDA disponibles para pacientes con DFT.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\">Procedimiento de estudio<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Se extrae sangre de los pacientes que cumplen los criterios de elegibilidad y se aplica a una tarjeta de filtro con etiqueta CE llamada CentoCard\u00ae que emplea tecnolog\u00eda de gotas de sangre seca (DBS).<\/p>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">Posteriormente, las muestras de sangre seca se analizan para detectar genes asociados con la demencia frontotemporal (DFT), incluidos <em>GRN<\/em> (progranulina), <em>MAPT<\/em> (prote\u00edna tau asociada a microt\u00fabulos), <em>C9ORF72<\/em> (marco de lectura abierto 72 del cromosoma 9) y otros.<\/p>\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Criterios de inclusi\u00f3n<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Criterios de inclusi\u00f3n<\/th><\/tr><\/thead><tbody><tr><td>El participante tiene entre 25 y 85 a\u00f1os.<\/td><\/tr><tr><td>El participante tiene FTD<\/td><\/tr><tr><td>Participante que presenta un cambio de comportamiento marcado<\/td><\/tr><tr><td>Participante que cumple los criterios diagn\u00f3sticos de afasia progresiva primaria (APP)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">\u00bfDe qu\u00e9 manera este estudio ayuda a los pacientes?<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Los resultados de las pruebas pueden confirmar un diagn\u00f3stico que tiene implicaciones para el paciente y su familia.<\/li>\n\n\n\n<li>Los pacientes pueden cumplir los criterios de elegibilidad para otros ensayos cl\u00ednicos seg\u00fan los resultados de las pruebas.<\/li>\n\n\n\n<li>El estudio EFRONT se lleva a cabo con el apoyo de Alector, Inc. Alector es una empresa de biotecnolog\u00eda en fase cl\u00ednica pionera en inmunoneurolog\u00eda, un novedoso enfoque terap\u00e9utico para el tratamiento de enfermedades neurodegenerativas. Alector ha descubierto y est\u00e1 desarrollando una amplia gama de programas para el sistema inmunitario innato, dise\u00f1ados para reparar funcionalmente las mutaciones gen\u00e9ticas que causan disfunci\u00f3n del sistema inmunitario cerebral y permitir que las c\u00e9lulas inmunitarias rejuvenecidas contrarresten las patolog\u00edas cerebrales emergentes.<\/li>\n<\/ul>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<h5 class=\"wp-block-heading\">Recursos<\/h5>\n\n\n\n<h4 class=\"wp-block-heading\">Enlaces \u00fatiles<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05075187?term=EFRONT&amp;draw=2&amp;rank=1\" target=\"_blank\" rel=\"noreferrer noopener\">Descubra c\u00f3mo puede participar: ClinicalTrials.gov<\/a><\/p>\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n  <section class=\"bloque-personalizado bloque-contact-info\" >     \n    <h2 class=\"mt-3 mb-5\"> Contacto Estudio EFRONT<\/h2>   \n    <div class=\"row justify-content-center bordesverticales\"> \n        <div class=\"bl-texto col-12 col-md-3\">\n         <h5 class=\"mt-0\">Para m\u00e1s informaci\u00f3n por favor contactar<\/h5>\n<p><strong>Dr. Jefri Jeya Paul, director s\u00e9nior de proyectos cl\u00ednicos<\/strong><br \/>\nDepartamento de Estudios Cl\u00ednicos<br \/>\nCENTOGENE GmbH<br \/>\nAm Strande 7<br \/>\n18055 Rostock<br \/>\nAlemania<br \/>\nCorreo electr\u00f3nico: <a title=\"Escribe un correo electr\u00f3nico\" href=\"mailto:jefri.paul@centogene.com\" data-mailto-vector=\"-4\">jefri.paul@centogene.com<\/a><\/p>\n        <\/div>\n        <div class=\"bl-texto  col-12 col-md-2\">\n          \n        <\/div>\n        <div class=\"bl-texto  col-12 col-md-3\">\n          <h5 class=\"mt-0\">Estudios cl\u00ednicos<\/h5>\n<h4>Acceso al estudio en CentoPortal para los m\u00e9dicos participantes<\/h4>\n<p><a class=\"btn btn-primary\" title=\"CentoPortal\" href=\"https:\/\/login.centoportal.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">CentoPortal<\/a><\/p>\n        <\/div>\n    <\/div>\n  <\/section>  \n\n  \n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":1078,"menu_order":20,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-44","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EFRONT | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/estudio-epidemiologico-en-la-demencia-frontotemporal-efront\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EFRONT | CENTOGENE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/estudio-epidemiologico-en-la-demencia-frontotemporal-efront\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-20T06:07:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/\",\"name\":\"EFRONT | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2025-02-12T12:47:59+00:00\",\"dateModified\":\"2025-05-20T06:07:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trial Support\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"EFRONT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EFRONT | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/estudio-epidemiologico-en-la-demencia-frontotemporal-efront\/","og_locale":"es_ES","og_type":"article","og_title":"EFRONT | CENTOGENE","og_url":"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/estudio-epidemiologico-en-la-demencia-frontotemporal-efront\/","og_site_name":"CENTOGENE","article_modified_time":"2025-05-20T06:07:27+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/","url":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/","name":"EFRONT | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2025-02-12T12:47:59+00:00","dateModified":"2025-05-20T06:07:27+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"Pharma","item":"https:\/\/www.centogene.com\/pharma\/"},{"@type":"ListItem","position":3,"name":"Clinical Trial Support","item":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/"},{"@type":"ListItem","position":4,"name":"EFRONT"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/44","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=44"}],"version-history":[{"count":4,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/44\/revisions"}],"predecessor-version":[{"id":5562,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/44\/revisions\/5562"}],"up":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/1078"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=44"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}